Editor’s Note: The Framework is subject to the Data Quality Act including the requirement that federally-disseminated documents posess “utility.” See here.
From: Bloomberg BNA/Chemical Reporter
By Pat Rizzuto
Nov. 27 — The federal approach to regulating bioengineered products is a confusing labyrinth, according to companies, trade associations, advocacy groups and scientists.
***
“Developers of products sometimes cannot easily ascertain whether potential products would be subject to regulations,” said the American Society of Plant Biologists, which joined nearly a thousand organizations and individuals that submitted comments on the Coordinated Framework for the Regulation of Biotechnology.